Press Releases
Latest ¦ 2009 ¦ 2008 ¦ 2007 ¦ 2006
August 10, 2010
Gregory Miller Joins Concert Pharmaceuticals as Head of Business and Corporate Development
August 3, 2010
Concert Pharmaceuticals to Present at Canaccord Genuity Global Growth Conference on August 10, 2010
May 20, 2010
Finalists for Ernst & Young Entrepreneur Of The Year® 2010 Awards in New England Announced; Roger Tung Named a Finalist
April 28, 2010
Concert Pharmaceuticals to Participate in Drug Discovery and Development Panel at 2010 BIO International Convention
April 15, 2010
Ernst & Young Entrepreneur Of The Year Award Semi-Finalists in New England announced; Roger Tung Selected a Semi-finalist
March 31, 2010
Concert Pharmaceuticals
Granted Patent for Deuterated Paroxetine Compounds, Including CTP-347
March 1, 2010
Concert Pharmaceuticals to Present at the 30th Annual Cowen and Company Health Care Conference on Monday, March 8
January 4, 2010
Concert Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11
[ back to top ]
December 9, 2009
Concert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board
November 9, 2009
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV; Concert Earns $12 Million Milestone from GlaxoSmithKline
November 3, 2009
Concert Pharmaceuticals to Participate on a Private Company Panel at the Merriman Curhan Ford 6th Annual Investor Summit
October 29, 2009
Concert Pharmaceuticals’ Roger Tung Awarded 2009 Mass High Tech All Star Award
October 20, 2009
Concert Pharmaceuticals to Present at Second Annual Boston Biotech R&D Conference
October 13, 2009
Concert Pharmaceuticals Selected by AlwaysOn as an OnDC Top 100 Winner; Recognized for Innovative Technology for Game-Changing New Medicines
September 14, 2009
Concert Pharmaceuticals Presents Clinical Results Demonstrating Reduced Drug-Drug Interactions with a Deuterium-Modified Compound; Phase I Results Presented at American College of Clinical Pharmacology
September 3, 2009
Concert Pharmaceuticals to Present at the Thomas Weisel Partners 2009 Healthcare Conference on September 10, 2009
August 18, 2009
Concert Pharmaceuticals' Justine Koenigsberg Named President of NIRI Boston for 2009-2010
June 2, 2009
Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
June 1, 2009
Concert Pharmaceuticals to Participate in the Private Company Forum at the 30th Annual Goldman Sachs Global Healthcare Conference
May 11, 2009
Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds
March 16, 2009
Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347; First Clinical Demonstration of Concert's Technology Platform
March 9, 2009
Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009
January 5, 2009
Concert Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12
[ back to top ]
November 24, 2008
Concert Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
October 28, 2008
Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
October 27, 2008
Concert Pharmaceuticals Announces Preclinical Results Suggesting Potential for Once Daily Dosing of Novel Oxazolidinone Antibiotic; Findings Presented at ICAAC/IDSA
October 15, 2008
Concert Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference
October 6, 2008
Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer
September 29, 2008
Concert Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
September 25, 2008
Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen; Results Presented at the North American Menopause Society's 2008 Annual Meeting
September 25, 2008
Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial; Potential Best-in-Class Non-Hormonal Treatment for Vasomotor Symptoms
June 24, 2008
Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008
April 30 , 2008
Conert Pharmaceuticals Raises $37 Million in Series C Financing
April 16 , 2008
Concert Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
March 11, 2008
Concert Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference
February 25, 2008
Concert Pharmaceuticals Profiled in BioCentury
January 3, 2008
Concert Pharmaceuticals Names W. James O’Shea and Daniel Grau to Product Advisory Board
January 2, 2008
Concert Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference
[ back to top ]
December 18, 2007
Concert Pharmaceuticals Appoints Dr. Ronald W. Barrett to the Company’s Board of Directors
December 13, 2007
Concert Pharmaceuticals Strengthens Executive Leadership Team
[ back to top ]
December 11, 2006
Peter Barton Hutt Appointed to Concert Pharmaceuticals
November 30, 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
September 15, 2006
Concert President and CEO Roger Tung Interviewed by SBS News
July 17, 2006
Concert Pharmaceuticals, Inc. Announces Financing of its Series A Round
[ back to top ]
|
